PT MDS Retailing (LPPF) Fundamentals 2026 — P/E 4.6x, Revenue Analysis | SniperIQ
PT MDS Retailing (LPPF) is a ID-listed Consumer Cyclical company in Department Stores with a market capitalization of Rp3.54T, trading at Rp1590.00 on the JKT. This SniperIQ fundamentals page covers PT MDS Retailing's valuation (P/E 4.6x, P/B 3.5x), profitability (net margin 8.7%), revenue (Rp5.78T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT MDS Retailing's market cap?
PT MDS Retailing (LPPF) has a market capitalization of approximately Rp3.54T, trading at Rp1590.00 on the JKT. Market cap moves with the live share price.
What is PT MDS Retailing's P/E ratio?
PT MDS Retailing's trailing twelve-month P/E ratio is 4.6x, with a price-to-book (P/B) of 3.5x. Valuation multiples are best compared with Consumer Cyclical sector peers rather than read in isolation.
How profitable is PT MDS Retailing?
PT MDS Retailing runs a net profit margin of 8.7%, a gross margin of 39.0%, and an operating margin of 12.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT MDS Retailing generate?
PT MDS Retailing reported revenue of Rp5.78T for fiscal year 2025, with net income of Rp725.4B and earnings per share (EPS) of 324.41. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT MDS Retailing pay a dividend?
PT MDS Retailing offers a trailing dividend yield of about 15.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PT MDS Retailing financially healthy?
PT MDS Retailing carries a debt-to-equity ratio of 2.41x and a current ratio of 0.96x, with a market beta of -0.02. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT MDS Retailing a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT MDS Retailing (LPPF) the key facts are: market cap Rp3.54T, P/E 4.6x, revenue Rp5.78T, 52-week range 1435-1990. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Cyclical peers and form your own view.
Track PT MDS Retailing's full fundamentals live
Get PT MDS Retailing's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.